Market Size in 2021 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 432.1 Million | USD 725.3 Million | 6.00% | 2021 |
The global automated endoscope reprocessors market was evaluated at $432.1 million in 2021 and is slated to hit $725.3 million by the end of 2030, with a CAGR of nearly 6.00% between 2022 and 2030
The market report is an indispensable guide on growth factors, challenges, restraints, and opportunities in the global marketplace. The report covers the geographical market along with a comprehensive competitive landscape analysis. Additionally, the report explores the investor and stakeholder space to help companies make data-driven decisions.
As per U.S. FDA, automated endoscope reprocessors are key medical instruments that finds key applications in healthcare surroundings for reprocessing endoscopes such as duodenoscopes and endoscope accessories. Reportedly, these medical devices are designed for killing microorganisms present on or within reusable endoscopes by exposing them to high proportion of disinfectants or sterilant solutions. Furthermore, healthcare units across the globe are shifting towards automated endoscope reprocessors use over flexible endoscopes. The reason being flexible endoscopes are manufactured from delicate raw materials and are difficult to disinfect and can infect patients with heptatis B, tuberculosis, and HIV.
Furthermore, automated endoscope reprocessors provide a slew of benefits over manual reprocessors such as reduction in human errors and minimizing exposure of persons to chemical sterilants. In addition to this, automated endoscope reprocessors also referred to as AERs improve consistency and minimize the health issues of the persons using high-level disinfectants (HLD). Apparently, automated endoscope reprocessors improve efficacy and reliability of endoscopy reprocessing through automation and standardization of various important reprocessing steps, thereby minimizing the probability of human errors. Apart from this, AERs use minimizes reprocessing persons exposure to hazardous chemical germicides and hence is recommended by The American Society for Gastrointestinal Endoscopy.
Key Insights
COVID-19 Impact Analysis
Outbreak of COVID-19 pandemic favourably influenced the expansion of automated endoscope reprocessors market across the globe. According to NIH researchers, improvement brought in endoscope reprocessing such as use of automated endoscope reprocessors by healthcare personnel during the COVID-19 pandemic helped them mitigate the risk of getting infected from COVID-19 after performing endoscopy on COVID-19 patients. This, in turn, contributed majorly to the demand for the medical devices in the healthcare industry. Moreover, the automated endoscope reprocessors proved effective in disinfecting endoscopy equipment along with facilitating its reusability, thereby contributing lucratively towards the revenue from increased sales of the automated endoscope reprocessors. This factor contributed sizably towards the expansion of the global automated endoscope reprocessors industry.
Massive product penetration in healthcare institutions such as clinics & hospitals expedite the global market growth
Humungous demand for value-based healthcare activities has played a key role in increasing the demand for automated endoscope reprocessors in the healthcare industry, thereby enlarging the scope of growth for the global automated endoscope reprocessors industry. Apart from this, surge in the rate of hospital acquired infections has translated into massive demand for automated endoscope reprocessors in hospitals & clinics. This has prompted the global automated endoscope reprocessors market growth trends. With automated endoscope reprocessors aiding in reducing the infections in patients, it is likely that the market for automated endoscope reprocessors is projected to expand by leaps & bounds.
Massive costs and risk of getting infected post endoscopic reprocessing procedures can impede the global market surge
Huge costs related to automated endoscope reprocessors and minimal or negligible risk of infections due to use of these equipment can hinder the growth of the global automated endoscope reprocessors market. In August 2016, the U.S. FDA recommended the people not to use Custom Ultrasonics Inc.’s 83 plus automated endoscope reprocessors for cleaning duodenoscopes after finding that the medical products were not properly validated. This can put brakes on the expansion of the global market in terms of both size and revenue. Moreover, risks of infection for healthcare persons during post endoscopic reprocessing procedures has posed a threat to the growth of the global industry.
Increase in the emergency medical surgeries on patients performed in hospitals has promoted high demand for automated endoscope reprocessors
Rise in number of medical surgeries in case of emergencies have created new facades of growth for the global automated endoscope reprocessors market. In addition, massive popularity and adoption of upgraded automated endoscope reprocessors over traditional medical devices have opened a spectrum of opportunities for the growth of automated endoscope reprocessors industry across the globe.
Complicated design of medical equipment and flawed reprocessing of reusable endoscopes can prove to be a core challenge for the growth of the global market
Complex design of the medical device and faulty reprocessing of reusable endoscopes has proved to be a key challenge for the growth of the automated endoscope reprocessors business. Furthermore, use of duodenoscopes poses a huge risk to patients getting cross-infected and this can prove to be a major challenge for the expansion of global automated endoscope reprocessors industry.
The global automated endoscope reprocessors market is divided into product type, modality, end user, and region.
Based on product type, the global automated endoscope reprocessors industry is segmented into single basin automated endoscope reprocessors and dual basin automated endoscope reprocessors. Moreover, dual basin automated endoscope reprocessors segment is set to exhibit lucrative growth during the forecast timeframe and account for the highest CAGR of about 6.9% during 2022-2030. The segmental growth can be attributed to beneficial features of the product that include monitoring every consecutive endoscope channel for blockage and providing a high rate of disinfection.
On basis on modality, the global automated endoscope reprocessors industry is segmented into standalone automated endoscope reprocessors and bench top automated endoscope reprocessors. Moreover, standalone automated endoscope reprocessors segment led the global automated endoscope reprocessors market share in 2021 and is set to dominate it even over the assessment timeline. The segmental growth can be due to immense demand for protective & easy-to-use medical devices with surging number of infections in hospitals Furthermore, growing inclination towards utilization of mobile endoscope reprocessors will boost segmental surge.
In terms of end user, the global automated endoscope reprocessors market is divided into ambulatory surgical centers, hospitals, and clinics segments. Moreover, hospitals segment, which led the growth of global market in 2021, is predicted to sketch a profitable growth curve for the automated endoscope reprocessors industry in the ensuing years. The growth of the segment during 2022-2030 can be attributed to massive usage of automated endoscope reprocessors in hospitals.
Report Attributes | Report Details |
---|---|
Report Name | Automated Endoscope Reprocessors Market Research Report |
Market Size in 2021 | USD 432.1 Million |
Market Forecast in 2030 | USD 725.3 Million |
Compound Annual Growth Rate | CAGR of 6.0% |
Number of Pages | 266 |
Forecast Units | Value (USD Million), and Volume (Units) |
Key Companies Covered | Custom Ultrasonics, Inc., STERIS Plc., Hoya Corporation, Olympus Corporation, Advanced Sterilization Products Services Inc, Laboratory Anios, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., and Johnson & Johnson. |
Segments Covered | By Product Type, By Modality, By End User And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Countries Covered | North America: U.S and Canada Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific Latin America: Brazil, Argentina, Chile The Middle East And Africa: South Africa, GCC, Rest of MEA |
Base Year | 2021 |
Historical Year | 2016 to 2020 |
Forecast Year | 2022 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
In terms of region, the global automated endoscope reprocessors industry is sector into the Asia-Pacific, Latin America, Europe, North America, and the Middle East and Africa. The North American region is slated to lead the global market expansion over the next eight years owing to massive popularity of automated endoscope reprocessors in the countries such as the U.S. Apart from this, presence of giant players such as Boston Scientific Corporation and Johnson & Johnson in the countries such as the U.S. will proliferate the regional market size. In addition, post-pandemic the U.S. government has recommended endoscope producers to either simplify the design of their endoscope or manufacture disposable endoscopes. This has paved way for huge preference for automated endoscope reprocessors in the country, thereby driving the regional market growth trends.
The global automated endoscope reprocessors market is led by participants such as:
By Product Type
By Modality
By End User
By Region
FrequentlyAsked Questions
The global automated endoscope reprocessors market is projected to expand over 2022-2030 owing to a surge in the rate of hospital acquired infections transforming into massive demand for automated endoscope reprocessors in hospitals & clinics. Apart from this, burgeoning demand for value-based healthcare activities has played a key role in increasing the demand for automated endoscope reprocessors in the healthcare industry, thereby enlarging the scope of growth for the global automated endoscope reprocessors industry.
According to study, the global automated endoscope reprocessors market size was $432.1 million in 2021 and is projected to reach $725.3 million by the end of 2030 with a compound annual growth rate (CAGR) of roughly 6.0% between 2022 and 2030.
The global automated endoscope reprocessors market is anticipated to be dominated by the North American region in the coming years owing to massive demand for automated endoscope reprocessors in the countries such as the U.S. Apart from this, presence of giant players such as Boston Scientific Corporation and Johnson & Johnson in the countries such as the U.S. will proliferate the regional market size.
The global automated endoscope reprocessors market is led by players like Custom Ultrasonics, Inc., STERIS Plc., Hoya Corporation, Olympus Corporation, Advanced Sterilization Products Services Inc, Laboratory Anios, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., and Johnson & Johnson.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed